---
figid: PMC9146348__ijms-23-05759-g004
pmcid: PMC9146348
image_filename: ijms-23-05759-g004.jpg
figure_link: /pmc/articles/PMC9146348/figure/ijms-23-05759-f004/
number: Figure 4
figure_title: ''
caption: VKORC1 reduces vitamin K epoxide, and is inhibited by warfarin. (A) VKORC1
  reduces vitamin K through an electron (eâˆ’) relay pathway. Redox protein generates
  thiols in VKORC1 located in the endoplasmic reticulum, which in turn generate membrane-embedded
  thiols that reduce vitamin K. (B) VKORC1 reduction of vitamin K epoxide (KO) to
  the vitamin K hydroquinone (KH2) carboxylase cofactor occurs in two reactions that
  involve a vitamin K quinone (K) intermediate. VKORC1 exists as a dimer [], which
  can explain how VKORC1 performs both reactions. (C) Sequestration of the K intermediate
  may increase the efficiency of VKD protein carboxylation []. One monomer converts
  KO to the K intermediate, which is then repositioned for further reduction to KH2
  by the second monomer. Warfarin uncouples the two VKORC1 reactions [], which alters
  full reduction by inhibiting the K to KH2 reaction much more strongly that the KO
  to K reaction. Full reduction during warfarin therapy may therefore result from
  a second reductase cooperating with VKORC1 to generate the KH2 carboxylase cofactor.
article_title: 'Vitamin K-Dependent Protein Activation: Normal Gamma-Glutamyl Carboxylation
  and Disruption in Disease.'
citation: Kathleen L. Berkner, et al. Int J Mol Sci. 2022 May;23(10):5759.
year: '2022'

doi: 10.3390/ijms23105759
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- processivity
- vitamin K
- vitamin K-dependent proteins
- gamma-glutamyl carboxylase (GGCX)
- vitamin K oxidoreductase (VKORC1)
- warfarin
- VKCFD
- pseudoxanthoma elasticum-like (PXE-like)

---
